Jun 5, 2020

World’s first study of potential COVID-19 antibody treatment in humans

Posted by in category: biotech/medical

The first patients have been dosed in a study of LY-CoV555, the lead antibody from Lilly’s collaboration with AbCellera. See our blog at:

Follow us on Twitter:
Follow us on Instagram:
Follow us on Facebook:
Follow us on Reddit:

Comments are closed.